BME100 s2014:T Group6 L2
![]() |
Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help | |||||
![]() | ||||||
OUR TEAM
LAB 2 WRITE-UPDescriptive StatisticsThe Effect of Lipopolysaccharide in Human Subjects Inflammotin Concentration by Dosage for 5mg Trial (pg/ml) Inflammotin Concentration by Dosage for 10mg Trial (pg/ml) Inflammotin Concentration by Dosage for 15mg Trial (pg/ml) The Effect of Lipopolysaccharide in Rat Subjects Inflammotin Concentration by Dosage for 10mg (pg/ml)
Results[Graphs unavailable]
AnalysisANOVA Test on the Effect of Lipopolysaccharide in Human Subjects conducted the ANOVA test since we had 4 separate groups with 10 subjects per group. Each group received a different dose of lipopolysaccharide incremented in 5 mg portions. ANOVA returned a p value of 1.401E-16 signifying a confidence several orders of magnitude greater than the required 0.05 p value. We followed up our analysis by including comparative T-Tests in order to demonstrate significance between each possible combination of paired groups. All returned T-Test values were found to be several orders of magnitude greater than the required confidence interval.
a T-Test which returned a p value of 0.867. This value does not correlate within our required interval of 0.05 which demonstrates that the lipopolysaccharide did not significantly induce Inflammotin accumulation.
Summary/DiscussionLipopolysaccharide has been found to be significant in human trials with greater than 99.99% confidence at all tested concentrations. Significance has also been demonstrated between test groups using T-Test analysis for all possible pair combinations. Rat trials however only demonstrate a confidence of 13.26% which does not meet the minimum 95% requirement. |